DRG Epidemiology's coverage of growth hormone deficiency (GHD) comprises epidemiological estimates of key patient populations across the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report both the incidence and prevalence of GHD for each country as well as annualized case counts projected to the national population.
DRG Epidemiology's GHD forecast will answer the following question:
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
Note: Coverage may vary by country.